Biotechnology company Dendreon Corporation, has developed what is believed to be a method for getting around prostate cancer’s ability to suppress the immune system’s cancer surveillance mechanisms. XVIVO visualized the mechanism of disease and also the proposed mechanism of action of a new class of drugs for fighting cancer’s immunosuppressant abilities.

“We were very pleased with the final product, the speed at which you team completed the rounds from story board to rough animation/final animation,  and the flexibility to change parts of the animation when our client came in with additional changes at the last hour.  Our client was also very happy with the final product.  In addition, Mike and Roz were very buttoned up with the communication flow, and always available when we needed to discuss changes.  It would be my pleasure to provide a recommendation if needed.”
Dr. Chris. Tobias, OmniGuide Project, Dudnyk